Generic Pipeline

Programs Under DevelopmentBranded Product EquivalentTherapeutic CategoryDevelopment Stage
Oxycodone Hydrochloride and Acetaminophen, USP 5 mg/325 mg, 7.5 mg/325 mg, 10 mg/325 mg TabletsPercocet®PainPending FDA Approval
Hydrocodone Bitartrate and Acetaminophen, USP 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg Tablets Norco®PainPending FDA Approval
Undisclosed GenericUndisclosedPainPending FDA Approval
Undisclosed GenericUndisclosedBariatricPending FDA Approval
Oxycodone Hydrochloride ER with ADT, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg and 80 mg TabletsOxyContin® ADTPainPending FDA Approval
Undisclosed GenericUndisclosedPainProcess Development
ELI-300 OpioidUndisclosedPainEarly Development
ELI-301 OpioidUndisclosedPainEarly Development
ELI-201 OpioidUndisclosedPainEarly Development